The role of synthetic coolants, WS-3 and WS-23, in modulating E-cigarette-induced reactive oxygen species (ROS) in lung epithelial cells.
Nonclinical
Respiratory Toxicity
In Vitro
Yogeswaran (2022)
Do Smokers’ Perceptions of the harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys.
Population Clinical
Cessation
Tobacco
Yong (2022)
Understanding the role of e-cigarette use in smoking cessation based on the stages of change model.
Population Clinical
Cessation
Tobacco
Yoon (2022)
association between electronic nicotine delivery systems and electronic non-nicotine delivery systems with initiation of tobacco use in individuals aged < 20 years. a systematic review and meta-analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Yoong (2021)
Pharmacokinetics of Propylene Glycol in humans During Multiple Dosing Regimens
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Yu (1985)
Preclinical assessment of Tobacco-Free Nicotine Pouches Demonstrates Reduced In Vitro Toxicity Compared with Tobacco Snus and Combustible Cigarette Smoke
Non-Clinical
Cytoxicity
In Vitro
Yu (2022)
Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and heated Tobacco Product on adipocyte Survival and Differentiation In Vitro.
Nonclinical
Cytotoxicity
Zagoriti (2020)
Nicotine dependence and intention to quit among electronic, conventional and dual cigarette users in Karachi.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Zaidi (2022)
Consumer Preferences for E-cigarette Flavor, Nicotine Strength, and Type: Evidence from Nielsen Scanner Data.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Zare (2021)